- Home
- DCTH vs NMCO Comparison
DCTH vs NMCO Comparison
Compare DCTH & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- NMCO
- Stock Information
- Founded
- DCTH 1988
- NMCO 2019
- Country
- DCTH United States
- NMCO United States
- Employees
- DCTH N/A
- NMCO N/A
- Industry
- DCTH Medical/Dental Instruments
- NMCO Finance/Investors Services
- Sector
- DCTH Health Care
- NMCO Finance
- Exchange
- DCTH Nasdaq
- NMCO Nasdaq
- Market Cap
- DCTH 630.4M
- NMCO 577.1M
- IPO Year
- DCTH N/A
- NMCO N/A
- Fundamental
- Price
- DCTH $13.85
- NMCO $10.36
- Analyst Decision
- DCTH Strong Buy
- NMCO
- Analyst Count
- DCTH 4
- NMCO 0
- Target Price
- DCTH $24.00
- NMCO N/A
- AVG Volume (30 Days)
- DCTH 531.5K
- NMCO 207.6K
- Earning Date
- DCTH 08-04-2025
- NMCO 01-01-0001
- Dividend Yield
- DCTH N/A
- NMCO 5.43%
- EPS Growth
- DCTH N/A
- NMCO N/A
- EPS
- DCTH N/A
- NMCO N/A
- Revenue
- DCTH $53,850,000.00
- NMCO N/A
- Revenue This Year
- DCTH $155.42
- NMCO N/A
- Revenue Next Year
- DCTH $37.93
- NMCO N/A
- P/E Ratio
- DCTH N/A
- NMCO N/A
- Revenue Growth
- DCTH 1068.87
- NMCO N/A
- 52 Week Low
- DCTH $7.17
- NMCO $8.52
- 52 Week High
- DCTH $18.23
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- DCTH 37.03
- NMCO 42.94
- Support Level
- DCTH $15.72
- NMCO $10.35
- Resistance Level
- DCTH $17.35
- NMCO $10.70
- Average True Range (ATR)
- DCTH 0.74
- NMCO 0.11
- MACD
- DCTH -0.40
- NMCO -0.03
- Stochastic Oscillator
- DCTH 2.23
- NMCO 2.86
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.